Xiaoli Liu, MD
Dr. Liu is passionate about individualized medicine using a genetics/genomics approach. In her current project, she is studying the reliability of procalcitonin as a marker to distinguish viral from bacterial infections in hospitalized patients, preventing unnecessary use of antibiotics and associated antibiotic over-use complications. She also studies pathogen DNA sequencing in patient samples, expecting that bacterial genomic data will help to guide clinicians toward more effective and timely management of infected patients.
Dr. Liu obtained her medical degree from Shandong Medical University in China, followed by a Master’s degree in Molecular Biology and Biochemistry, with an interest in understanding disease pathogenesis from a genetic and molecular level. Her research work focused on the effect of 9-cis-retinoic acid on human lung cancer. After relocating to the United States, Dr. Liu worked at University of Alabama at Birmingham as a research assistant, with studies involving cystic fibrosis and Hurler’s syndrome, before joining Scripps.